Article Details

Obalon Therapeutics Inc (OBLN) Receives Consensus Rating of “Hold” from Analysts

Retrieved on: 2019-04-10 14:33:45

Tags for this article:

Click the tags to see associated articles and topics

Obalon Therapeutics Inc (OBLN) Receives Consensus Rating of “Hold” from Analysts. View article details on hiswai:

Excerpt

<div>Finally, <b>Renaissance Technologies</b> LLC lifted its holdings in Obalon Therapeutics by 43.2% during the 3rd quarter. <b>Renaissance Technologies</b> LLC ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up